Rybelsus Hair Loss: How Common, How Long It Lasts
The Rybelsus label does not include hair loss as a side effect. What people mean by it: more hair than usual coming out. Labels call it hair loss or alopecia.
- In the label
- Not listed
- Most common in the label
- Nausea 20%
A quick look at Rybelsus
The half-life is about 1 week. After 7 d, half is gone, and after five half-lives (35 d), about 3% remains.
In PIONEER 1, people with type 2 diabetes lost 3.7 kg over 26 weeks, compared with 1.4 kg on placebo.
Monthly prices in US dollars include the list price and self-pay offers. Each comes from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.
What the Rybelsus label lists instead
The Rybelsus label does not include hair loss. It lists five side effects most often, and these are them.
| Side effect | Placebo | Rybelsus 7 mg | Rybelsus 14 mg | More than placebo, 14 mg |
|---|---|---|---|---|
| Nausea | 6% | 11% | 20% | +14 points |
| Abdominal Pain | 4% | 10% | 11% | +7 points |
| Diarrhea | 4% | 9% | 10% | +6 points |
| Decreased appetite | 1% | 6% | 9% | +8 points |
| Vomiting | 3% | 6% | 8% | +5 points |
The Rybelsus label (DailyMed) is the source.
Hair loss and other GLP-1s
Each label covers its own trials, and the people in each study group differ. View it as a rough guide.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
| 5% | 5 mg | 1% | Adults with obesity or overweight (weight management) | |
| 5% | 17.2 mg | 2% | Adults with obesity or overweight (weight management) | |
| 3% | 2.4 mg | 1% | Adults with obesity or overweight (weight management) | |
| Listed, no rate given | – | – | – | |
| Listed, no rate given | – | – | – | |
| Listed, no rate given | – | – | – | |
| Byetta | Listed, no rate given | – | – | – |
| Not listed | – | – | – | |
| Not listed | – | – | – | |
| Not listed | – | – | – |
Sources: Wegovy label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed).
The FDA label (DailyMed) is the source.